These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 34446633)

  • 1. [KASID Guidance for Clinical Practice Management of Adult Inflammatory Bowel Disease during the COVID-19 Pandemic: Expert Consensus Statement].
    Park YE; Lee YJ; Chang JY; Song HJ; Kim DH; Yang YJ; Kim BC; Lee JG; Yang HC; Choi M; Kim SE; Myung SJ;
    Korean J Gastroenterol; 2021 Aug; 78(2):105-116. PubMed ID: 34446633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [SARS-CoV-2 Vaccination for Adult Patients with Inflammatory Bowel Disease: Expert Consensus Statements by KASID].
    Lee YJ; Kim SE; Park YE; Chang JY; Song HJ; Kim DH; Yang YJ; Kim BC; Lee JG; Yang HC; Choi M; Myung SJ;
    Korean J Gastroenterol; 2021 Aug; 78(2):117-128. PubMed ID: 34446634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Korean Association for the Study of Intestinal Diseases guidance for clinical practice of adult inflammatory bowel disease during the coronavirus disease 2019 pandemic: expert consensus statements.
    Park YE; Lee YJ; Chang JY; Song HJ; Kim DH; Yang YJ; Kim BC; Lee JG; Yang HC; Choi M; Kim SE; Myung SJ
    Intest Res; 2022 Oct; 20(4):431-444. PubMed ID: 34974675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 vaccination for adult patients with inflammatory bowel disease: expert consensus statement by KASID.
    Lee YJ; Kim SE; Park YE; Chang JY; Song HJ; Kim DH; Yang YJ; Kim BC; Lee JG; Yang HC; Choi M; Myung SJ;
    Intest Res; 2022 Apr; 20(2):171-183. PubMed ID: 34974674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future.
    Viganò C; Mulinacci G; Palermo A; Barisani D; Pirola L; Fichera M; Invernizzi P; Massironi S
    World J Gastroenterol; 2021 Sep; 27(33):5520-5535. PubMed ID: 34588749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expert Opinions on the Current Therapeutic Management of Inflammatory Bowel Disease during the COVID-19 Pandemic: Japan IBD COVID-19 Taskforce, Intractable Diseases, the Health and Labor Sciences Research.
    Nakase H; Matsumoto T; Matsuura M; Iijima H; Matsuoka K; Ohmiya N; Ishihara S; Hirai F; Wagatsuma K; Yokoyama Y; Hisamatsu T
    Digestion; 2021; 102(5):814-822. PubMed ID: 32892197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review on medical management of inflammatory bowel disease during the coronavirus disease 2019 pandemic.
    Chela H; Pasha SB; Wan XF; Ghouri YA
    J Gastroenterol Hepatol; 2021 Apr; 36(4):918-926. PubMed ID: 32876952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty.
    Aysha AA; Rentsch C; Prentice R; Johnson D; Bryant RV; Ward MG; Costello SP; Lewindon P; Ghaly S; Connor SJ; Begun J; Christensen B
    Intern Med J; 2020 Jul; 50(7):798-804. PubMed ID: 32656985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period.
    Iacucci M; Cannatelli R; Labarile N; Mao R; Panaccione R; Danese S; Kochhar GS; Ghosh S; Shen B
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):598-606. PubMed ID: 32305075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic.
    Lin S; Lau LH; Chanchlani N; Kennedy NA; Ng SC
    Gut; 2022 Jul; 71(7):1426-1439. PubMed ID: 35477864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical advice for management of inflammatory bowel diseases patients during the COVID-19 pandemic: World Endoscopy Organization Statement.
    Neumann H; Emura F; Bokemeyer B; Guda N; Tajiri H; Matsumoto T; Rubin DT
    Dig Endosc; 2020 Jul; 32(5):658-662. PubMed ID: 32369646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of Societal Recommendations Regarding Management of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic.
    Grossberg LB; Pellish RS; Cheifetz AS; Feuerstein JD
    Inflamm Bowel Dis; 2021 May; 27(6):940-946. PubMed ID: 32619010
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of inflammatory bowel disease during the COVID-19 pandemic.
    Hisamatsu T
    Immunol Med; 2022 Sep; 45(3):128-135. PubMed ID: 34530694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal inflammatory bowel disease management during the global coronavirus disease 2019 pandemic.
    El Ouali S; Rubin DT; Cohen BL; Regueiro MD; Rieder F
    Curr Opin Gastroenterol; 2021 Jul; 37(4):313-319. PubMed ID: 33859104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory bowel disease and SARS-CoV-2 pandemic: current knowledge and recommendations.
    Bekic D; Belosic Halle Z
    Scand J Gastroenterol; 2021 Jun; 56(6):656-660. PubMed ID: 33765405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidance for Restarting Inflammatory Bowel Disease Therapy in Patients Who Withheld Immunosuppressant Medications During COVID-19.
    Siegel CA; Christensen B; Kornbluth A; Rosh JR; Kappelman MD; Ungaro RC; Johnson DF; Chapman S; Wohl DA; Mantzaris GJ
    J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S769-S773. PubMed ID: 33085972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 in patients with inflammatory bowel disease.
    Anikhindi SA; Kumar A; Arora A
    Expert Rev Gastroenterol Hepatol; 2020 Dec; 14(12):1187-1193. PubMed ID: 32856955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician.
    Chebli JMF; Queiroz NSF; Damião AOMC; Chebli LA; Costa MHM; Parra RS
    World J Gastroenterol; 2021 Mar; 27(11):1022-1042. PubMed ID: 33776370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Best Practice Guidance for Adult Infusion Centres during the COVID-19 Pandemic: Report from the COVID-19 International Organization for the Study of IBD [IOIBD] Task Force.
    Dotan I; Panaccione R; Kaplan GG; O'Morain C; Lindsay JO; Abreu MT
    J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S785-S790. PubMed ID: 32959882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Trials for Inflammatory Bowel Disease: Global Guidance During the COVID-19 Pandemic.
    Reinisch W; Danese S; Peyrin-Biroulet L; Loftus EV
    J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S815-S819. PubMed ID: 32520311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.